Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection.
Publication
, Journal Article
Zhao, Y; Maule, J; McCracken, J; Li, Y; Rapisardo, S; Yang, L-H; Wang, E
Published in: British journal of haematology
May 2020
Published In
British journal of haematology
DOI
EISSN
1365-2141
ISSN
0007-1048
Publication Date
May 2020
Volume
189
Issue
3
Start / End Page
e64 / e67
Related Subject Headings
- Middle Aged
- Megakaryocyte Progenitor Cells
- Male
- Leukemia, Myeloid, Acute
- Induction Chemotherapy
- Immunology
- Humans
- Clone Cells
- Cell Lineage
- Cell Differentiation
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhao, Y., Maule, J., McCracken, J., Li, Y., Rapisardo, S., Yang, L.-H., & Wang, E. (2020). Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection. British Journal of Haematology, 189(3), e64–e67. https://doi.org/10.1111/bjh.16476
Zhao, Yue, Jake Maule, Jenna McCracken, Yang Li, Sarah Rapisardo, Lian-He Yang, and Endi Wang. “Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection.” British Journal of Haematology 189, no. 3 (May 2020): e64–67. https://doi.org/10.1111/bjh.16476.
Zhao Y, Maule J, McCracken J, Li Y, Rapisardo S, Yang L-H, et al. Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection. British journal of haematology. 2020 May;189(3):e64–7.
Zhao, Yue, et al. “Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection.” British Journal of Haematology, vol. 189, no. 3, May 2020, pp. e64–67. Epmc, doi:10.1111/bjh.16476.
Zhao Y, Maule J, McCracken J, Li Y, Rapisardo S, Yang L-H, Wang E. Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection. British journal of haematology. 2020 May;189(3):e64–e67.
Published In
British journal of haematology
DOI
EISSN
1365-2141
ISSN
0007-1048
Publication Date
May 2020
Volume
189
Issue
3
Start / End Page
e64 / e67
Related Subject Headings
- Middle Aged
- Megakaryocyte Progenitor Cells
- Male
- Leukemia, Myeloid, Acute
- Induction Chemotherapy
- Immunology
- Humans
- Clone Cells
- Cell Lineage
- Cell Differentiation